Literature DB >> 26003990

Progression of gyrate atrophy measured with ultra-wide-field imaging.

Guillermo Salcedo-Villanueva1,2, Miguel Paciuc-Beja3,4, Cristina Villanueva-Mendoza5, Mariana Harasawa3, Jesse M Smith4, Raul Velez-Montoya4, Jeffrey L Olson4, Scott C Oliver4, Naresh Mandava4, Hugo Quiroz-Mercado3,4.   

Abstract

The study aims to determine the progression of gyrate atrophy by measuring the area growth of chorioretinal atrophic lesions using ultra-wide-field images (UWFI). A retrospective, observational, and comparative study was conducted and UWFI (200°) were obtained from two patients with gyrate atrophy at baseline and follow-up. Measurements of atrophy were obtained for three types of lesions: Solitary atrophic lesions (SAL), De novo solitary lesions (DNSL), and peripapillary atrophy (PPA). Comparison of baseline and follow-up was done using t tests. Two patients with gyrate atrophy were included. Patient 1 presented 16 SAL, 5 DNSL, and PPA measured for both eyes (BE). Overall area growth (OAG) for SAL (expressed in decimals) presented a mean of 3.41, σ 3.07. DNSL area for BE presented a mean of 1586.08 P (2), σ 1069.55. OAG for PPA presented a mean of 1.21, σ 0.17. Patient 2 presented 5 SAL, no DNSL, and PPA was measured for BE. OAG for SAL presented a mean of 1.58, σ 1.05 (range 1.02-3.47). OAG for PPA presented a mean of 1.05, σ 0.001. Gyrate atrophy progression can be determined by measuring the changes in area using UWFI.

Entities:  

Keywords:  Choroid; Gyrate atrophy; Retina; Retina pigment epithelium; Retinal distrophies

Mesh:

Year:  2015        PMID: 26003990     DOI: 10.1007/s10792-015-0085-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  19 in total

1.  [Gyrate atrophy of the choroid and retina: a case report].

Authors:  D Lahbil; M Hamdani; M D'khissy; M El Belhadji; R Rachid; N Laouissi; K Zaghloul; A Amraoui
Journal:  J Fr Ophtalmol       Date:  2000-10       Impact factor: 0.818

2.  Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina.

Authors:  T Wang; G Steel; A H Milam; D Valle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Raised plasma-ornithine and gyrate atrophy of the choroid and retina.

Authors:  O Simell; K Takki
Journal:  Lancet       Date:  1973-05-12       Impact factor: 79.321

4.  Gyrate atrophy of the choroid and retina associated with hyperornithinaemia.

Authors:  K Takki
Journal:  Br J Ophthalmol       Date:  1974-01       Impact factor: 4.638

5.  The natural history of gyrate atrophy of the choroid and retina.

Authors:  K K Takki; R C Milton
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

6.  Assessment of visual function in patients with gyrate atrophy who are considered candidates for gene replacement.

Authors:  R C Caruso; R B Nussenblatt; K G Csaky; D Valle; M I Kaiser-Kupfer
Journal:  Arch Ophthalmol       Date:  2001-05

7.  Gyrate atrophy of the choroid and retina: further experience with long-term reduction of ornithine levels in children.

Authors:  Muriel I Kaiser-Kupfer; Rafael C Caruso; David Valle
Journal:  Arch Ophthalmol       Date:  2002-02

8.  Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation.

Authors:  Agnes B Renner; Andreas Walter; Britta S Fiebig; Herbert Jägle
Journal:  Doc Ophthalmol       Date:  2012-06-07       Impact factor: 2.379

9.  Experimental model of gyrate atrophy in animals.

Authors:  T Kuwabara; Y Ishikawa; M I Kaiser-Kupfer
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

10.  Gyrate atrophy of the retina: inborn error of L-ornithin:2-oxoacid aminotransferase.

Authors:  J J O'Donnell; R P Sandman; S R Martin
Journal:  Science       Date:  1978-04-14       Impact factor: 47.728

View more
  1 in total

Review 1.  Structural evaluation in inherited retinal diseases.

Authors:  Malena Daich Varela; Burak Esener; Shaima A Hashem; Thales Antonio Cabral de Guimaraes; Michalis Georgiou; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2021-05-12       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.